Trial Profile
Open Label Phase II Immunotherapy Trial of Inoperable Pancreatic Cancer
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs V3 P (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors Immunitor
- 29 May 2017 New trial record